Frontiers in Cardiovascular Medicine | Heart Failure and Transplantation

Case Report

Published on 15 Jun 2023

Case report: Sudden unexpected death due to tuberculous myocarditis involving sinus node at autopsy

in Heart Failure and Transplantation

Le Zhang
He Yan
Yufang Wang
Feijun Huang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1159292

3,052 views
1 citation

Opinion

Published on 15 Jun 2023

Phenotyping myocardial injury related to COVID and SARS-CoV-2 vaccination: insights from cardiovascular magnetic resonance

in Heart Failure and Transplantation

Ria Garg
Muzna Hussain
Matthias G. Friedrich

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1186556

1,713 views
2 citations

Clinical Trial

Published on 14 Jun 2023

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial

in Heart Failure and Transplantation

Teng Ma
Jian Zhao
Yechao Yan
Junying Liu
Jie Zang
Yaqi Zhang
Kun Ruan
Hong Xu
Wan He

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1178153

1,832 views
6 citations

Opinion

Published on 12 Jun 2023

Should GDMT be prioritized over revascularization in new onset HFrEF? Potential lessons from the REVIVED-BCIS2 and STRONG-HF trials

in Heart Failure and Transplantation

Neal M. Dixit
Ezra A. Amsterdam

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1193226

4,060 views

Editorial

Published on 12 Jun 2023

Editorial: Long-term perspectives in advanced heart failure therapies

in Heart Failure and Transplantation

Felix Schoenrath
Finn Gustafsson
Claudius Mahr
Ivan Netuka

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1220000

1,154 views

Original Research

Published on 12 Jun 2023

The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is “response” the right answer?

in Heart Failure and Transplantation

Matteo Beltrami
Alessandro Galluzzo
Riccardo Tappa Brocci
Alessandro Paoletti Perini
Paolo Pieragnoli
Manuel Garofalo
Geza Halasz
Massimo Milli
Maria Barilli
Alberto Palazzuoli

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1180960

1,723 views
2 citations

Original Research

Published on 08 Jun 2023

Optimal treatment for post-MI heart failure in rats: dapagliflozin first, adding sacubitril-valsartan 2 weeks later

in Heart Failure and Transplantation

Wenqi Tao
Xiaoyu Yang
Qing Zhang
Shuli Bi
Zhuhua Yao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1181473

2,716 views
3 citations

Original Research

Published on 06 Jun 2023

Association of GSDMD with microvascular-ischemia reperfusion injury after ST-elevation myocardial infarction

in Heart Failure and Transplantation

Wenjing Sun
Chunqiu Wang
Shihua Cui
Yan Wang
Shenghui Zhao
Min Lu
Fan Yang
Shujuan Dong
Yingjie Chu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1138352

1,777 views

Original Research

Published on 05 Jun 2023

Trends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study

in Heart Failure and Transplantation

Yukang Mao
Qiangqiang Fu
Feng Su
Wenjia Zhang
Zhong Zhang
Yimeng Zhou
Chuanxi Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1182606

3,345 views
3 citations

Review

Published on 02 Jun 2023

Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies

in Heart Failure and Transplantation

Tauben Averbuch
James A. White
Nowell M. Fine

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1152568

8,305 views
14 citations

Review

Published on 02 Jun 2023

Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets

in Heart Failure and Transplantation

Michele Correale
Lucia Tricarico
Francesca Croella
Simona Alfieri
Francesco Fioretti
Natale Daniele Brunetti
Riccardo M. Inciardi
Savina Nodari

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1157472

4,821 views
7 citations

Original Research

Published on 02 Jun 2023

Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure

in Heart Failure and Transplantation

Andraž Nendl
Sajan C. Raju
Kaspar Broch
Cristiane C. K. Mayerhofer
Kristian Holm
Bente Halvorsen
Knut Tore Lappegård
Samuel Moscavitch
Johannes Roksund Hov
Ingebjørg Seljeflot

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1160030

2,844 views
6 citations

Original Research

Published on 01 Jun 2023

Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis

in Heart Failure and Transplantation

Jan Malik
Anna Valerianova
Satu Sinikka Pesickova
Kristyna Michalickova
Zuzana Hladinova
Zdenka Hruskova
Vladimira Bednarova
Katarina Rocinova
Monika Tothova
Marketa Kratochvilova

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1130618

3,157 views
6 citations

Original Research

Published on 30 May 2023

The impact of geriatric nutritional risk index on one-year outcomes in hospitalized elderly patients with heart failure

in Heart Failure and Transplantation

Masakazu Miura
Shinichi Okuda
Kazuhiro Murata
Yutaka Ohno
Satoshi Katou
Fumiaki Nakao
Takeshi Ueyama
Takeshi Yamamoto
Yasuhiro Ikeda

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1190548

19,136 views
5 citations

Review

Published on 30 May 2023

Assessment and diagnosis of right ventricular failure—retrospection and future directions

in Heart Failure and Transplantation

Sun Kyun Ro
Kei Sato
Shinichi Ijuin
Declan Sela
Gabriele Fior
Silver Heinsar
Ji Young Kim
Jonathan Chan
Hideaki Nonaka
Aaron C. W. Lin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1030864

8,684 views
6 citations

Mini Review

Published on 26 May 2023

Tricuspid regurgitation in the setting of LVAD support

in Heart Failure and Transplantation

Ananya Mitra
Aleem Siddique

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1090150

2,659 views

Navigation group

Articles

Case report: Sudden unexpected death due to tuberculous myocarditis involving sinus node at autopsy

Phenotyping myocardial injury related to COVID and SARS-CoV-2 vaccination: insights from cardiovascular magnetic resonance

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial

Should GDMT be prioritized over revascularization in new onset HFrEF? Potential lessons from the REVIVED-BCIS2 and STRONG-HF trials

Editorial: Long-term perspectives in advanced heart failure therapies

The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is “response” the right answer?

Optimal treatment for post-MI heart failure in rats: dapagliflozin first, adding sacubitril-valsartan 2 weeks later

Association of GSDMD with microvascular-ischemia reperfusion injury after ST-elevation myocardial infarction

Trends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study

Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies

Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets

Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure

Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis

The impact of geriatric nutritional risk index on one-year outcomes in hospitalized elderly patients with heart failure

Assessment and diagnosis of right ventricular failure—retrospection and future directions

Tricuspid regurgitation in the setting of LVAD support